Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

Altimmune, Inc.

Wed, Aug 4, 2021, 4:01 PM1 min read

In this article:

GAITHERSBURG, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 11, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am E.T. to discuss the second quarter 2021 financial results and provide a business update.

Conference Call Information:

Date:	Wednesday, August 11
Time:	8:30 am Eastern Time
Domestic Dial-in:	(844) 615-6509
International Dial-in:	(918) 922-3148
Conference ID:	9484516
Webcast:	https://edge.media-server.com/mmc/p/ne5cqqtf

About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor and Media Contact:
Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com

Trump Media stock jumps for second day as company goes to battle with short sellers
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Yahoo Finance•7h ago
Netflix reports strong subscriber gains, but Q2 revenue forecast disappoints
Netflix reported first quarter earnings after the bell on Thursday. Here's what to know.
Yahoo Finance•4h ago
Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.
The insurer was accused by a short-seller of "extensive" fraud.
Motley Fool•2d ago
The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
Motley Fool•16h ago
DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.
An FAQ on the Truth Social owner’s website gave stockholders multiple ways to avoid their shares being lent to short sellers.
Barrons.com•3h ago
Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
Kinder Morgan's (KMI) Q1 earnings gain from increased financial contributions from the Natural Gas Pipelines, Products Pipelines and Terminals business segments.
Zacks•8h ago
Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Benzinga•10h ago
4 Members of Congress Generated Triple-Digit Returns in the Stock Market Last Year: These Are the 3 Stocks They Bought
These members of Congress delivered greater returns than Warren Buffett in 2023.
Motley Fool•15h ago
Ask an Advisor: ‘Should I Be Moving Stocks to Bonds?' I'm 65 and Have 82% of My 401(k) in Equities
In my 401(k) retirement plan, I’m 82% stocks. I’m 65 and still working. Should I be moving my stocks to bonds? -Bob While it's not a satisfying answer, the real answer is that "it depends." The decision of whether to shift your 401(k) to a more conservative asset allocation will depend primarily on your longer-term […] The post Ask an Advisor: ‘Should I Be Moving Stocks to Bonds?’ I’m 65 and Have 82% of My 401(k) in Equities appeared first on SmartReads by SmartAsset.
SmartAsset•9h ago
'We've evolved': Netflix explains decision to stop reporting crucial subscriber data
Netflix will no longer report membership numbers starting next year.
Yahoo Finance•2h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

Recommended Stories

Trump Media stock jumps for second day as company goes to battle with short sellers

Netflix reports strong subscriber gains, but Q2 revenue forecast disappoints

Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.

The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock

DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.

Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend

Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'

4 Members of Congress Generated Triple-Digit Returns in the Stock Market Last Year: These Are the 3 Stocks They Bought

Ask an Advisor: ‘Should I Be Moving Stocks to Bonds?' I'm 65 and Have 82% of My 401(k) in Equities

'We've evolved': Netflix explains decision to stop reporting crucial subscriber data